J&J shares down despite guidance raise as MedTech revenues disappoint

J&J shares down despite guidance raise as MedTech revenues disappoint  Seeking Alpha

Summary aggregated from Seeking Alpha's public RSS feed. The full reporting belongs to Seeking Alpha — please read it on their site.